Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 8.90 billion. The enterprise value is 7.98 billion.
Market Cap | 8.90B |
Enterprise Value | 7.98B |
Important Dates
The next estimated earnings date is Wednesday, September 11, 2024.
Earnings Date | Sep 11, 2024 |
Ex-Dividend Date | Jul 30, 2024 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Shares Outstanding | 69.30M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | -0.18% |
Owned by Insiders (%) | 2.97% |
Owned by Institutions (%) | 19.86% |
Float | 55.87M |
Valuation Ratios
The trailing PE ratio is 17.85 and the forward PE ratio is 23.32.
PE Ratio | 17.85 |
Forward PE | 23.32 |
PS Ratio | 4.38 |
PB Ratio | 2.82 |
P/FCF Ratio | 12.65 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.25, with an EV/FCF ratio of 11.33.
EV / Earnings | 15.90 |
EV / Sales | 3.93 |
EV / EBITDA | 10.25 |
EV / EBIT | 12.84 |
EV / FCF | 11.33 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 26.33.
Current Ratio | 2.43 |
Quick Ratio | 2.09 |
Debt / Equity | 26.33 |
Debt / EBITDA | 1.07 |
Debt / FCF | 1.18 |
Interest Coverage | 56.89 |
Financial Efficiency
Return on equity (ROE) is 16.48% and return on invested capital (ROIC) is 9.96%.
Return on Equity (ROE) | 16.48% |
Return on Assets (ROA) | 8.24% |
Return on Capital (ROIC) | 9.96% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.43 |
Inventory Turnover | 3.92 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.98% in the last 52 weeks. The beta is 0.50, so Bioteque's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | +18.98% |
50-Day Moving Average | 133.97 |
200-Day Moving Average | 123.34 |
Relative Strength Index (RSI) | 33.96 |
Average Volume (20 Days) | 188,115 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.03 billion and earned 501.47 million in profits. Earnings per share was 7.20.
Revenue | 2.03B |
Gross Profit | 875.66M |
Operating Income | 621.00M |
Pretax Income | 628.09M |
Net Income | 501.47M |
EBITDA | 763.47M |
EBIT | 621.00M |
Earnings Per Share (EPS) | 7.20 |
Balance Sheet
The company has 1.76 billion in cash and 830.89 million in debt, giving a net cash position of 928.98 million or 13.41 per share.
Cash & Cash Equivalents | 1.76B |
Total Debt | 830.89M |
Net Cash | 928.98M |
Net Cash Per Share | 13.41 |
Equity (Book Value) | 3.16B |
Book Value Per Share | 45.53 |
Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was 799.76 million and capital expenditures -95.94 million, giving a free cash flow of 703.82 million.
Operating Cash Flow | 799.76M |
Capital Expenditures | -95.94M |
Free Cash Flow | 703.82M |
FCF Per Share | 10.16 |
Margins
Gross margin is 43.10%, with operating and profit margins of 30.57% and 24.68%.
Gross Margin | 43.10% |
Operating Margin | 30.57% |
Pretax Margin | 30.92% |
Profit Margin | 24.68% |
EBITDA Margin | 37.58% |
EBIT Margin | 30.57% |
FCF Margin | 34.64% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 3.46%.
Dividend Per Share | 4.50 |
Dividend Yield | 3.46% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 62.19% |
Buyback Yield | 0.01% |
Shareholder Yield | 3.47% |
Earnings Yield | 5.60% |
FCF Yield | 7.90% |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
Last Split Date | Aug 20, 2015 |
Split Type | Reverse |
Split Ratio | 0.8006917977 |